N-Butyl-N-(4-hydroxybutyl)nitrosamine
CAS: 3817-11-6
Ref. 3D-FB177815
| 1g | Discontinued | ||
| 2g | Discontinued | ||
| 5g | Discontinued | ||
| 10g | Discontinued | ||
| 25g | Discontinued |
Product Information
Name:
N-Butyl-N-(4-hydroxybutyl)nitrosamine
Synonyms:
- 1-Butanol, 4-(butylnitrosamino)-
- 1-Butanol, 4-(butylnitrosoamino)-
- 4-(Butylnitrosoamino)-1-butanol
- 4-Hydroxybutylbutylnitrosamine
- 4-[Butyl(Nitroso)Amino]Butan-1-Ol
- Butyl(4-hydroxybutyl)nitrosamine
- N-Butyl-N-(1-hydroxybutyl)nitrosamine
- N-Nitrosobutyl-4-hydroxybutylamine
- N-Nitrosobutylbutan-4-olamine
- N-n-Butyl-N-butan-4-ol-nitrosamine
- See more synonyms
Description:
N-Butyl-N-(4-hydroxybutyl)nitrosamine (BBN) is a genotoxic carcinogen that causes urothelial carcinoma in laboratory animals. It is also a potential biomarker for bladder cancer in humans, based on the detection of BBN in maternal blood and urine. The pharmacological mechanism of BBN is not yet clear, but it may be due to its sodium salt or the presence of other genotoxic chemicals. A rat model has been developed for BBN toxicity studies. This drug inhibits protein synthesis by inhibiting RNA polymerase II and III, which are responsible for gene transcription and translation respectively.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
174.24 g/mol
Formula:
C8H18N2O2
Purity:
90%Min
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
